Skip to content
Politically.com Search all
Menu

2026 · 2nd Quarter (Apr 1 - June 30)

AMGEN, INC.

Filed by MILLER STRATEGIES, LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 20, 2026
Income
$60,000.00
Expenses
Not reported
Filing UUID
1ce4b9e9-92c8-4e50-8a27-ad73746318ca
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

IMM · Immigration

Issues related to visas

HCR · Health Issues

Healthcare policy issues as they relate to the pharmaceutical industry including drug pricing and biosimilars

MMM · Medicare/Medicaid

Issues related to drug pricing, biosimilars, Medicare Part D and Medicare Part B; H.R. 3517 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021

Literal federal measure citations: H.R. 3517

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.